Triphenylphosphonium and D-α-tocopheryl polyethylene glycol 1000 succinate-modified, tanshinone IIA-loaded lipid-polymeric nanocarriers for the targeted therapy of myocardial infarction

Triphenylphosphonium and D-α-tocopheryl polyethylene glycol 1000 succinate-modified, tanshinone IIA-loaded lipid-polymeric nanocarriers for the targeted therapy of myocardial infarction

Shouwen Zhang, Jingfang Li, Shunpeng Hu, Fangfang Wu, Xianzhao Zhang Department of Cardiology, Linyi People’s Hospital, Linyi, People’s Republic of China Background: Cardiovascular diseases (CVDs) are the leading causes of mortality worldwide. Currently, the best treatment opti...

Full description

Bibliographic Details
Main Authors: Zhang S, Li J, Hu S, Wu F, Zhang X
Format: Article
Language:English
Published: Dove Medical Press 2018-07-01
Series:International Journal of Nanomedicine
Subjects:
Myocardial infarction
mitochondria targeting
lipid-polymeric nanocarriers
D-α-tocopheryl polyethylene glycol 1000 succinate
triphenylphosphonium
Tanshinone IIA
Online Access:https://www.dovepress.com/triphenylphosphonium-and-d-alpha-tocopheryl-polyethylene-glycol-1000-s-peer-reviewed-article-IJN

Internet

https://www.dovepress.com/triphenylphosphonium-and-d-alpha-tocopheryl-polyethylene-glycol-1000-s-peer-reviewed-article-IJN

Similar Items